报价延迟最少15分钟:2026/03/11 23:57 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
24.84 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-20.75/4.22
|
|
企业价值
2.69B
|
| 资产负债 |
|
每股账面净值
26.02
|
| 现金流量 |
|
现金流量率
0.16
|
| 损益表 |
|
收益
2.25B
|
|
每股收益
29.04
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recoverysegment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries. |
